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Assessment of Echo-Attenuated Plaque by
Optical Coherence Tomography and its Impact on
Post-Procedural Creatine Kinase-Myocardial Band
Elevation in Elective Stent Implantation
Tetsumin Lee, MD,* Tsunekazu Kakuta, MD,* Taishi Yonetsu, MD,*
Kentaro Takahashi, MD,* Ginga Yamamoto, MD,* Yoshito Iesaka, MD,*
Hideomi Fujiwara, MD,* Mitsuaki Isobe, MD†
Tsuchiura and Tokyo, Japan
Objectives This study examined morphological characteristics of echo-attenuated plaques by optical
coherence tomography (OCT) and evaluated their inﬂuence on creatine kinase-myocardial band (CK-MB)
elevation after percutaneous coronary intervention (PCI) in patients with elective stent implantation.
Background Recent intravascular ultrasound studies have described atherosclerotic plaques with echo atten-
ation (EA) without associated bright echoes that are correlated with no-reﬂow phenomenon after PCI.
ethods We studied 135 native de novo culprit coronary lesions in 135 patients with normal pre-
CI CK-MB levels (28 with unstable angina; 107 with stable angina) who underwent intravascular
ltrasound and OCT examinations before elective stent implantation. The lesions were divided into
groups based on the presence or absence of EA, and OCT ﬁndings were compared. We then de-
ermined predictors of post-PCI CK-MB elevation.
esults EA was found in 47 (34.8%) lesions and was associated with the presence of OCT-derived
hin-capped ﬁbroatheroma, ruptured plaques, greater lipid content, intravascular ultrasound–derived
arge reference and plaque area, lesion eccentricity, and microcalciﬁcation. Elevated CK-MB levels
ere observed in 36 (26.7%) lesions, and signiﬁcantly more frequently in lesions with EA than with-
ut. In multivariable analysis, EA (odds ratio [OR]: 3.49; 95% conﬁdence interval [CI]: 1.53 to 7.93;
 0.003) and OCT-derived ruptured plaque (OR: 2.92; 95% CI: 1.21 to 7.06; p  0.017) were inde-
pendent predictors of post-PCI CK-MB elevation.
Conclusions Atherosclerotic plaques with EA were associated with characteristics considered to be
high risk or unstable. OCT examination showed an additive predictive value to the presence of EA
for post-PCI CK-MB elevation. (J Am Coll Cardiol Intv 2011;4:483–91) © 2011 by the American
College of Cardiology Foundation
From the *Department of Cardiology, Tsuchiura Kyodo Hospital, Tsuchiura, Japan; and the †Department of Cardiovascular
Medicine, Tokyo Medical and Dental University, Tokyo, Japan. All authors have reported that they have no relationships to
disclose.Manuscript received August 16, 2010; revised manuscript received November 29, 2010, accepted December 9, 2010.
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484Intravascular ultrasound (IVUS) can predict no-reflow or
creatine kinase-myocardial band (CK-MB) elevation after
percutaneous coronary intervention (PCI) based on charac-
teristics such as a large plaque burden, intracoronary mobile
mass, and lipid pool-like appearance (1–3). In addition,
ecent studies have described atherosclerotic plaques that
how echo signal attenuation (EA) without associated bright
choes in patients with coronary artery disease, that is,
ssociated with no-reflow and worse clinical outcome after
CI because of distal embolization (4–6). The ultrasound
ntensity of signal backscatter is affected by a number of
actors, including tissue reflectivity and ultrasound power.
See page 492
Coronary atherectomy speci-
mens obtained from lesions with
EA have shown the presence of
predominantly lipid-rich plaque
with microcalcification (4). How-
ever, very dense fibrous tissue may
also produce EA (7). Lee et al. (5)
reported that an echo-attenuated
plaque is an exclusive marker of
lesion instability observed only
in patients with acute coronary
syndrome, whereas others (4,6)
detected a significant number
of echo-attenuated plaques in
stable lesions. Optical coher-
ence tomography (OCT) is a high-
resolution imaging method for
plaque characterization provid-
ing information on plaque struc-
tures and tissue characterization,
such as the presence of thin-
capped fibroatheroma (TCFA),
lipid-rich plaques, which are con-
sidered responsible for plaque insta-
ility, and intracoronary thrombi (8–12). Therefore, we hy-
othesized that OCT may allow us to elucidate the relevant
orphological features of culprit coronary lesions with EA.
o test this hypothesis, we evaluated plaques with and
ithout EA by pre-PCI OCT examination in patients
reated with elective stenting to investigate if lesions with
A are associated with OCT-derived high-risk plaque
haracteristics. We further hypothesized that OCT may
llow us to detect lesion-related factors associated with
ost-PCI CK-MB elevation in these patients.
ethods
Study population. From December 2008 to December
Abbreviations
and Acronyms
CK-MB  creatine kinase-
yocardial band
SA  cross-sectional area
A  echo attenuation
EM  external elastic
embrane
VUS  intravascular
ltrasound
CT  optical coherence
omography
CI  percutaneous
oronary intervention
AP  stable angina
ectoris
CFA  thin-capped
broatheroma
IMI  Thrombosis In
yocardial Infarction
AP  unstable angina
ectoris009, we prospectively enrolled 148 patients (32 with fnstable angina pectoris [UAP] and 116 with stable angina
ectoris [SAP]) without CK-MB elevation before PCI who
nderwent nonemergency stent implantation at single, na-
ive, de novo culprit coronary lesions at Tsuchiura Kyodo
ospital. Both IVUS and OCT examinations were per-
ormed before PCI. The study protocol was approved by the
nstitutional review board, and all patients provided written
nformed consent before PCI. Patients treated with multi-
essel coronary intervention were excluded (1 UAP patient
nd 3 SAP patients). Patients were also excluded if they had
ignificant left main disease (2 SAP patients), congestive
eart failure, or renal insufficiency with baseline serum
reatinine1.8 mg/dl (133 mol/l). In addition, those with
xtremely tortuous vessels or heavy calcification were ex-
luded because of expected difficulty in advancing the OCT
nd/or IVUS catheters. We defined UAP as having a progres-
ive crescendo pattern or angina at rest without an increase
n troponin I. We defined SAP as no change in frequency,
uration, or intensity of anginal symptoms within 6 weeks
efore PCI. The target lesion was identified by a combina-
ion of coronary angiograms, left ventricular wall motion
bnormalities, electrocardiogram findings, angiographic le-
ion morphology, and scintigraphic defects. All included
atients had angina, documented myocardial ischemia, or
oth. Three UAP patients and 4 SAP patients were further
xcluded from the analysis because of failure of the imaging
atheter in crossing the lesion or unsatisfactory image
uality. Thus, 28 UAP lesions and 107 SAP lesions from 135
atients were eventually analyzed in the present study. The
resence of EA on IVUS was defined as an atherosclerotic
laque showing ultrasound signal attenuation without very
igh intensity echo reflectors that involved 90° of the vessel
ircumference and a length1 mm. Lesions were divided into
he group with EA in a culprit lesion (attenuated group) and
he group without EA (nonattenuated group).
Percutaneous coronary intervention procedure. All patients
eceived treatment with aspirin (200 mg/day) and clopi-
ogrel (75 mg/day, 300-mg loading dose) at least 24 h
efore PCI. All patients received an intravenous bolus
njection of 10,000 IU of heparin and intracoronary isosor-
ide dinitrate (2 mg) before angiography. PCI procedures
ere performed using a 6-F guiding catheter via the radial
pproach in all patients. Coronary stent implantation was
erformed with a balloon pre-dilation. Balloon/artery ratio
or pre-dilation was 0.9 to 1.0 in all patients. To avoid
ggressive stent expansion, stent size was guided by the
ombination of on-line quantitative coronary angiography
nd IVUS, although the type of stent was selected at the
perator’s discretion. Angiographic criteria of 25% resid-
al stenosis were adopted as successful PCI. After achieving
his endpoint, IVUS examination was performed to confirm
ptimal stent deployment and additional PCI was per-
ormed in case of a suboptimal result.
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485Quantitative coronary angiography analysis. Quantitative
coronary angiography analysis was performed using a CMS-
MEDIS system (Medis Medical Imaging Systems, Inc.,
Leiden, the Netherlands). The minimum lumen diameter,
reference diameter, and lesion length were measured in
diastolic frames from orthogonal projections. Coronary flow
was assessed according to the Thrombolysis In Myocardial
Infarction (TIMI) flow grade and corrected TIMI frame
count (13,14).
CK-MB analysis. We took CK-MB measurements at the
time of admission, within 1 h before PCI, 6 h and 20 h after
PCI completion, and thereafter with an interval of 6 h if still
continuing to increase. CK-MB activity was determined
using an immunoinhibition assay and confirmed by mass
assay technique. The maximum CK-MB value was consid-
ered to represent presence or absence of post-PCI CK-MB
elevation. CK-MB elevation was defined as a level above the
upper reference limit (URL) (16 IU/l).
OCT image acquisition and analysis. OCT image acquisition
as performed using M3-CV and Image Wire 2 catheters
LightLab Imaging, Westford, Massachusetts) throughout
he study. This system provides an axial resolution of 10 to
5 m, lateral resolution of 20 to 40 m, and 20 frames/s
with 240 lines/frame. After obtaining control angiograms,
the imaging wire was positioned distal to the region of
interest with an occlusion balloon catheter (Herios, Light-
Lab Imaging) located proximal to the lesion. If the lesion
presented with tortuosity or severe stenosis and could not be
crossed by the imaging catheter, we first advanced a con-
ventional coronary guidewire (0.014 inch) across the lesion
before replacing it with the OCT imaging wire over the
balloon catheter. The lesions for which pre-dilation using a
balloon was required to cross the OCT imaging wire were
excluded. For clearing the operative field, the occlusion
balloon was inflated to 0.5 atm, and Lactated Ringer’s
solution was continuously infused into the coronary artery
through the distal tip of the occlusion catheter at 0.5 ml/s.
The entire lesion’s length was imaged with an automated
pullback system at 1 mm/s. When a lesion was located close
(1 cm) to the ostium of the coronary arteries, we used the
ontinuous-flushing nonocclusive technique for OCT im-
ging (15). To eliminate blood from the vessel without
cclusion, we infused commercially available dextran-40 and
actated Ringer’s solution (Low molecular dextran L,
tsuka Pharmaceutical Factory, Tokushima, Japan) directly
rom the guiding catheter at a rate of 3.0 to 4.0 ml/s using
power injector (Angimat Illumena, Liebel-Flarsheim,
incinnati, Ohio). Lesions with images showing significant
ignal attenuation but precluding satisfactory evaluation and
eliable morphological measurement were excluded from
he analysis. The image data were digitally stored for offline
nalysis. Using fluoroscopic reference and landmarks such as
he aorto-ostial junction, proximal and distal side branches,
nd sites of calcification in combination with the constantullback speed of the imaging wire and the OCT findings of
ach plaque, image location of all target sites could be deter-
ined and compared with IVUS findings. Offline analysis
as performed with proprietary software (LightLab Imag-
ng). The OCT data were analyzed by 2 independent
nvestigators blinded to the angiographic and clinical
ndings using previously validated criteria for OCT
laque characterization (9,10,16). Discordance between
nvestigators was resolved by consensus reading. The
ipid content of a plaque was semiquantified as the
umber of involved quadrants on cross-sectional OCT
mages. For each plaque, the cross-sectional image with
he highest number of lipid quadrants was used for
urther analysis. For all images of the culprit plaque with
n OCT-determined lipid core, the overlying fibrous cap
hickness was measured at its thinnest part. For each
ulprit plaque, the minimum value was used for subse-
uent analysis. When the number of lipid-containing
uadrants was 2, it was considered as a lipid-rich
laque, whereas a TCFA was defined as a lipid-rich
laque with a fibrous cap thickness 70 m. We also
examined for fibrous cap disruption and an intracoronary
thrombi. Fibrous cap disruption was identified by the
presence of fibrous cap discontinuity and cavity formation
in the plaque, and a plaque with fibrous cap disruption
was defined as a ruptured plaque. In the ruptured plaque,
the residual fibrous cap was identified as a flap between
the lumen and the cavity of the plaque, and its thickness
was measured at the thinnest part. Intracoronary thrombi
were identified by mass images protruding into the
lumen. Interobserver and intraobserver differences were
assessed by evaluation by 2 observers and by 1 observer at
2 separate time points, respectively.
IVUS image acquisition and analysis. After OCT examina-
tion, IVUS imaging was attempted for all patients before
any PCI procedure after intracoronary administration of
200 g of nitroglycerin using a 40-MHz IVUS catheter
(Boston Scientific, Natick, Massachusetts). The catheter
was advanced distal (10 mm) to the target lesion up to
a distal landmark point documented by angiography.
Automated pullback at 0.5 mm/s was then performed
from this point to the aorto-ostial junction. IVUS images
were digitally stored for subsequent offline analysis. Two
independent investigators blinded to the angiographic,
OCT, and other clinical data analyzed the IVUS images.
Discordance between the observers was settled by con-
sensus reading. Qualitative and quantitative IVUS anal-
ysis was performed according to the American College of
Cardiology Clinical Expert Consensus Document (7).
Lesion site was at the minimum lumen cross-sectional
area (CSA). Using planimetry software (QCU-CMS,
Medis Medical Imaging Systems, Inc.), external elastic
membrane (EEM) and lumen CSAs were measured.
Plaque plus media CSA was calculated as EEM minus
T
E
w

m
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 5 , 2 0 1 1
M A Y 2 0 1 1 : 4 8 3 – 9 1
Lee et al.
Characterization of Echo-Attenuated Plaque by OCT
486lumen CSA, and plaque burden was calculated as plaque
plus media divided by EEM CSA. If the EEM circum-
ference could not be identified, we interpolated the EEM
area. The location of the echo-attenuated portion of the
plaque was documented for comparison with the OCT find-
ings. Proximal and distal references were single slices with the
larger lumen and smallest plaque burden within 10 mm
proximally and distally, but occurring before any large side
Figure 1. Echo-Attenuated Plaques and Corresponding OCT Images
Echo-attenuated plaques (A1, B1, and C1) and the corresponding optical coh
thin-capped ﬁbroatheroma (A2) and large thrombus (B2) at the echo attenuat
the EA site (C2).branch. The eccentricity was the ratio of maximum to mini-
mum plaque thickness; lesions were characterized as concentric
when the ratio was 2 and eccentric when the ratio was 2.
he remodeling index was defined as the ratio of the lesion
EM CSA to the reference EEM CSA. Positive remodeling
as defined as remodeling index of1.05. Bright echoes with
90° of acoustic shadowing of a size 1 mm were defined as
ild calcifications.
tomography (OCT) images (A2, B2, and C2). The OCT examination showed
A) site. A lipid-rich plaque with a thick ﬁbrous cap was detected on OCT aterence
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487Statistical analysis. SPSS (version 14.0, SPSS, Inc., Chi-
ago, Illinois) was used for all analyses. Categorical data
ere expressed as absolute frequencies and percentages and
ere compared using the chi-square or Fisher exact tests, as
ppropriate. Continuous variables were expressed as mean 
D for normally distributed variables and as median (25th
o 75th percentile) for not normally distributed variables;
hey were compared using Student t test and Mann-
hitney U tests, respectively. Interobserver and intraob-
erver variabilities of IVUS and OCT findings were assessed
y the kappa statistic of concordance. Trend tests were
erformed to test the relationship between OCT-derived
haracteristics and peak CK-MB category. To control for
ultiple comparisons, pairwise tests were performed. The
elationship between CK-MB elevation (dependent vari-
ble), the presence of EA, OCT findings, and other
otential confounders were assessed using multivariable
ogistic regression analysis (stepwise forward method) to
ssess whether EA remained associated with CK-MB
levation. The associated variables in univariable analyses
p  0.2) were included in the model. The Hosmer and
emeshow test was used to establish the goodness-of-fit of
he model. A p value of 0.05 indicates that the model
rovides a valid representation. We considered p  0.05 to
ndicate statistical significance.
esults
IVUS and OCT images were available for analysis in 28
culprit lesions in 28 UAP patients and 107 culprit lesions in
107 SAP patients. Attenuated plaques were found in 47 le-
sions (34.8%): 6 of 28 (21.4%) in UAP; 41 of 107 (38.3%)
in SAP; p  0.12. Representative images are shown in
igure 1.
Patient characteristics, angiographic, and procedural results.
There were no differences in age, sex, clinical presentation,
and cardiovascular risk factors between the 2 groups (Table 1).
Angiographic data (Table 2) showed that attenuated plaques
were observed more frequently in the right coronary artery
and less frequently in the left anterior descending coronary
artery. In all patients, successful stenting was performed.
Drug-eluting stents were used more often in patients from
the nonattenuated group. Baseline TIMI flow grade and
corrected TIMI frame count did not differ between the 2
groups. Immediately after balloon angioplasty and at final
angiography, the TIMI flow grade and corrected TIMI frame
count were both significantly worse in the attenuated group.
IVUS ﬁndings. Plaque burden, eccentricity index, lesion EEM,
nd reference EEM area values were significantly greater in
he attenuated group, whereas the lesion lumen area was
imilar between the 2 groups (Table 3). Mild calcification
as more frequently detected in the attenuated lesions thann nonattenuated lesions (p 0.01). We observed EA at the rinimal lumen CSA site in 45 lesions (95.7%), proximally
n 1 lesion (2.1%), and distally in 1 lesion (2.1%).
OCT ﬁndings. OCT revealed that the frequency of TCFA
was significantly greater in the attenuated group than in the
nonattenuated group (Table 4). The fibrous cap thickness of
lipid-rich plaques in the attenuated group was significantly
lesser than that in the nonattenuated group.
Predictors of post-PCI CK-MB elevation. Elevated post-PCI
CK-MB levels were observed in 36 patients and more
frequently in the attenuated group: in 21 lesions with EA
(21 of 47, 44.7%) and 15 lesions without EA (15 of 88,
17.0%); p  0.001. When lesions with elevated CK-MB
levels were divided into 2 groups (3 URL and1 to 3
RL), the frequencies of EA, TCFA, and ruptured plaques
ncreased proportionally to the magnitude of CK-MB ele-
ation levels (Fig. 2), whereas the frequency of thrombi
as not statistically different among the groups (16.2%,
3.3%, and 33.3%, respectively, p  0.48). Fibrous cap
hickness was significantly thinner in the highest CK-MB
levation group (Fig. 3). When patients with plaque rup-
ure (n  32) were divided into 2 groups on the basis of
A, the peak CK-MB levels were significantly greater in
he attenuated group with ruptured plaques (n  16) than
n the nonattenuated group with ruptured plaques (n  16)
20 IU/l [interquartile range (IQR): 14 to 76 IU/l] vs. 13
U/l [IQR: 8 to 18 IU/l], p  0.01), whereas the frequency
f post-PCI CK-MB elevation was not statistically different
etween the 2 groups (62.5% vs. 31.3%, p  0.16).
ultivariable analysis revealed that factors independently
ssociated with post-PCI CK-MB were EA (OR: 3.49;
5% CI: 1.53 to 7.93; p  0.003) and OCT-derived
Table 1. Patient Characteristics
Attenuated Group
(n  47)
Nonattenuated Group
(n  88) p Value
Age, yrs 67.0 10.5 64.6 10.2 0.20
Female 6 (12.8) 20 (22.7) 0.20
Diabetes mellitus 15 (31.9) 35 (39.8) 0.46
Hypertension 37 (78.7) 63 (71.6) 0.42
Current smoker 24 (51.1) 39 (44.3) 0.47
Previous MI 12 (25.5) 20 (22.7) 0.88
UAP 6 (12.8) 22 (25.0) 0.12
CRP, mg/dl 0.06 (0.00–0.25) 0.06 (0.00–0.52) 0.44
WBC, counts/l 6,354 1,469 6,404 1,820 0.87
Total cholesterol, mg/dl 194 36 198 40 0.61
LDL cholesterol, mg/dl 122 31 120 33 0.76
HDL cholesterol, mg/dl 44 14 45 11 0.64
Peak CK-MB, IU/l 15 (10–20) 11 (9–15) 0.003
Statin use 26 (55.3) 43 (48.9) 0.59
Values are mean SD, n (%), or median (25th to 75th percentile).
CK-MB  creatine kinase-myocardial band; CRP  C-reactive protein; HDL  high-density
lipoprotein; LDL low-density lipoprotein; MImyocardial infarction; UAP unstable angina
pectoris; WBCwhite blood cell.uptured plaque (OR: 2.92; 95% CI: 1.21 to 7.06; p 
a
c
i
v
y
s
(
0
D
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 5 , 2 0 1 1
M A Y 2 0 1 1 : 4 8 3 – 9 1
Lee et al.
Characterization of Echo-Attenuated Plaque by OCT
4880.017) (Table 5). In attenuated plaques with plaque rupture,
the OR of post-PCI CK-MB elevation increased to 5.96
(95% CI: 1.98 to 17.93; p  0.001) as compared to lesions
without these 2 characteristics. The Hosmer and Lemeshow
test provided p values of 0.997, which indicated a proper
goodness-of-fit for the model.
Intraobserver and interobserver variability. Intraobserver
nd interobserver variability of IVUS findings yielded good
oncordance for the presence of EA (kappa  0.91 for
ntraobserver variability and kappa  0.85 for interobserver
ariability). Intraobserver variability of OCT findings
ielded high concordance, whereas interobserver variability
howed slightly lower concordance for lipid quadrants
kappa  0.90 vs. 0.83), identification of TCFA (kappa 
Table 2. Angiographic Findings
Attenuated Gro
(n  47)
Lesion location
RCA 28 (59.6)
LAD 9 (19.1)
LCX 10 (21.3)
Pre-MLD, mm 1.06 0.34
Pre-RD, mm 3.21 0.47
Stenosis, % 66.5 10.9
Lesion length, mm 15.3 (12.1–19.6
ACC/AHA classiﬁcation B2/C 28 (59.6)
Post-MLD, mm 3.29 0.43
Post-dilation pressure, atm 15.3 2.5
Stented length, mm 24 (20–32)
Acute gain, mm 2.21 0.60
Drug-eluting stents 31 (66.0)
TIMI ﬂow grade
Before procedure
0–1 1 (2.1)
2 2 (4.3)
3 44 (93.6)
After balloon angioplasty
0–1 1 (2.1)
2 16 (34.0)
3 30 (63.8)
At ﬁnal angiogram
0–1 1 (2.1)
2 7 (14.9)
3 39 (83.0)
CTFC
Before procedure 25 (20–27)
After balloon angioplasty 27 (21–34)
At ﬁnal angiogram 21 (18–26)
Values are n (%), mean SD, or median (25th to 75th percentile).
ACC/AHA American College of Cardiology/American Heart Assoc
LCX left circumflex; MLDminimal lumen diameter; RCA right c
Infarction..83 vs. 0.77), and thrombus (kappa  0.92 vs. 0.84).iscussion
Our major findings are as follows: 1) an attenuated plaque was
found in 34.8% of the present cohort; 2) the minimum lumen
site was located at the attenuated portion of the culprit plaque
in the majority (95.7%) of lesions in the attenuated group; 3)
the echo-attenuated plaque was associated with high-risk
characteristics, such as large reference area, greater plaque
burden, lesion eccentricity, microcalcification, large lipid arc,
ruptured plaque, and the presence of TCFA; 4) post-PCI
CK-MB elevation was observed more frequently in the atten-
uated group; and 5) EA lesions noted on IVUS and the
presence of ruptured plaques on OCT were independent
predictors of post-PCI CK-MB elevation in patients treated
Nonattenuated Group
(n  88) p Value
0.001
31 (35.2)
45 (51.1)
12 (13.6)
1.00 0.37 0.32
2.84 0.57 0.001
64.7 11.8 0.38
13.5 (10.5–19.2) 0.28
41 (46.6) 0.21
3.07 0.43 0.004
15.9 3.2 0.25
28 (23–35) 0.12
2.05 0.48 0.11
74 (84.1) 0.028
0.22
1 (1.1)
12 (13.6)
75 (85.2)
0.003
1 (1.1)
9 (10.2)
78 (88.6)
0.002
0 (0.0)
1 (1.1)
87 (98.9)
24 (19–27) 0.66
20 (14–26) 0.001
18 (13–23) 0.006
CTFC corrected TIMI frame count; LAD left anterior descending;
artery; RD reference diameter; TIMI Thrombolysis In Myocardialup
)
iation;
oronarywith elective stenting.
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489We consider that our findings contribute to the understand-
ing of attenuated plaques and their potential relationship to
plaque instability. The intensity of the backscattered ultra-
sound depends on several factors including the ultrasound
reflectivity of the tissue. Coronary atherectomy specimens from
attenuated plaques show predominantly lipid-rich plaques with
microcalcification compared with nonattenuated plaques (4).
rregular distribution of microcalcification and cholesterol
lefts and large volumes of these plaque components may cause
ltrasound dispersion and signal attenuation behind the plaque
17). Our finding that attenuated plaques are associated with
CFA is in line with these previous observations. TCFA is
haracterized by macrophage infiltration and a large necrotic
ore (11,12). A large plaque burden also contributes to EA
ecause of greater distance of ultrasound penetration causing
ower diminishment in the far field. The presence of TCFA
ay also cause signal attenuation from the luminal surface
ecause IVUS resolution (100 to 150 m) cannot detect a
thin cap. Thrombi are another potential cause of EA. An
Table 3. Intravascular Ultrasound Findings
Attenuated Group
(n  47)
Nonattenuated Group
(n  88) p Value
Lesion EEM CSA, mm2 18.9 5.9 14.2 5.3 0.001
Lesion lumen CSA, mm2 2.24 0.65 2.25 0.64 0.97
Lesion plaque area, mm2 16.7 5.7 11.9 5.2 0.001
Lesion plaque burden, % 87.4 4.1 82.7 6.4 0.001
Reference EEM CSA, mm2 17.9 5.1 14.1 4.3 0.001
Positive remodeling 26 (55.3) 34 (38.6) 0.094
Remodeling index 1.06 0.19 1.01 0.18 0.097
Eccentricity 37 (78.7) 46 (52.3) 0.005
Lipid-pool 10 (21.3) 10 (11.4) 0.20
Mild calciﬁcation 25 (53.2) 26 (29.5) 0.012
Ruptured plaque 7 (14.9) 5 (5.7) 0.11
Values are mean SD or n (%).
CSA cross-sectional area; EEM external elastic membrane.
Table 4. OCT Findings
Attenuated Group
(n  47)
Nonattenuated Group
(n  88) p Value
TCFA 24 (51.1) 19 (21.6) 0.001
Ruptured plaque 16 (34.0) 16 (18.2) 0.064
Thrombus 6 (12.8) 16 (18.2) 0.47
Lipid-rich plaque 42 (89.4) 49 (55.7) 0.001
Thinnest cap thickness, m 60 (50–100) 85 (60–120) 0.005
Lipid quadrants 0.003
0 2 (4.3) 20 (22.7)
1 (90°) 3 (6.4) 19 (21.6)
2 (90°, 180°) 11 (23.4) 14 (15.9)
3 (180°, 270°) 16 (34.0) 20 (22.7)
4 (270°) 15 (31.9) 15 (17.0)
Values are n (%) or median (25th to 75th percentile).TCFA thin-capped fibroatheroma.animal study suggested that white thrombi might produce
greater attenuated ultrasound signal intensity compared
with erythrocyte-rich thrombi because white thrombi gen-
erally contain more densely homogenous cellular compo-
nents (18). The previous findings by Lee et al. (5) agree with
his observation; they concluded that EA is a finding limited
o culprit lesions associated with acute coronary syndrome.
n contrast, other reports found EA not only in lesions with
cute coronary syndrome but also in SAP (4–6). Our OCT
xaminations revealed that thrombi might exist in EA
esions, although there was no significant difference in the
requency of thrombi between attenuated and nonattenu-
ted groups. Taken together, our results support the
ypothesis that EA is predominantly caused by a com-
ination of factors considered related to plaque instabil-
ty, such as large vessel size, large plaque burden, eccen-
ricity, microcalcification, plaque rupture, and the
resence of TCFA. The present study cohort represents
elatively stable patients without pre-PCI CK-MB ele-
Figure 2. Frequencies of Ruptured Plaques, TCFAs, and EA by
Peak CK-MB Category
All of these features increased proportionally to the magnitude of creatine
kinase-myocardial band (CK-MB) elevation levels. TCFA  thin-capped ﬁbro-
atheroma; URL  upper reference limit; other abbreviations as in Figure 1.
Figure 3. Thinnest Fibrous Cap Thickness by Peak CK-MB Category
Thinnest cap thickness was signiﬁcantly thinner in the highest CK-MB
elevation category than other categories. Abbreviations as in Figure 2.
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490vation. Whether our findings are applicable to EA of the
lesions in more unstable patients with acute myocardial
infarction remains to be elucidated.
Multivariable analysis demonstrated that EA and the
presence of OCT-derived ruptured plaques are independent
predictors of post-PCI CK-MB elevation. Severe, acute
complications are rare, but a mild and asymptomatic release
of the biocardiac markers of myocardial necrosis is fre-
quently observed after an otherwise technically successful
coronary intervention. Although the pathophysiology of
post-PCI myocardial necrosis is multifactorial, emboliza-
tion of debris or calcified plaque material, or exposure of
thrombogenic material to the coronary flow, which may
cause thrombus formation, all seem to play key roles. A
recent prospective cohort study by Cavallini et al. (19)
reported that the degree of post-PCI CK-MB elevation in
patients with normal baseline CK-MB level independently
predicted the risk of death after PCI, and even minor
increases of CK-MB affected 2-year mortality. Interest-
ingly, an increase in post-PCI troponin I did not affect
2-year mortality and, therefore, added no further prognostic
information to that offered by CK-MB elevation. Our study
demonstrated that lesions with EA are at high risk for
post-PCI myocardial injury; moreover, OCT examination
may provide further risk stratification for distal emboliza-
tion of these high-risk lesions. The relationship between the
presence of plaque rupture and potential CK-MB elevation
may indicate that the plaques that are most susceptible to
distal embolization following PCI also contain the greatest
amount of lipid-rich thrombogenic necrotic materials,
which may also cause EA. Therefore, we suggest that distal
Table 5. Analysis of Factors Related to CK-MB Eleva
Univariate Logisti
p Value OR
RCA 0.041 2.25
ACC/AHA classiﬁcation B2/C 0.032 2.40
Lesion length 0.043 1.03
QCA RD 0.120 1.70
Attenuated plaque 0.002 8.45
Positive remodeling 0.120 1.84
Lesion EEM CSA 0.032 1.07
Lesion plaque area 0.027 1.08
Reference EEM CSA 0.087 1.07
Lipid-rich plaque 0.037 8.86
TCFA 0.007 2.96
Ruptured plaque 0.004 3.45
Lipid quadrants 3 to 4 0.038 2.30
Cap thickness 0.150 0.99
CI  confidence interval; OR  odds ratio; PCI  percutaneous c
thin-capped fibroatheroma; other abbreviations as in Tables 1, 2, andprotection devices or other therapeutic approaches may be wpotentially effective in reducing the release of plaque mate-
rials from selective EA lesions in the case of plaque rupture.
Study limitations. First, the present study was a prospective
ut nonconsecutive series of a relatively small number of
ubjects who met the eligibility criteria and consented to the
tudy. Excluding patients or lesions, such as patients with
ignificant left main disease, renal impairment, tortuous
essels, or long lesions, may have resulted in a selection bias.
econd, the presence of thrombi at the culprit lesion may
isturb the accurate assessment of underlying plaque struc-
ures by OCT. However, the frequency of thrombi was
elatively low in the present study because most of the
atients had stable angina. We consider that it is not likely
o affect our conclusions. Third, a theoretical possibility of
issed CK-MB elevation due to the chosen sampling
indows always exists, although we used a widely accepted
rotocol of periodic CK-MB determination. Fourth, we
annot exclude the possibility that the occlusion or contin-
ous flushing required for OCT imaging, the guidewire, or
he OCT imaging wire itself may have altered plaque
orphology and the results subsequently obtained by IVUS.
ifth, myocardial necrosis or its location induced by PCI
as not confirmed by contrast-enhanced magnetic reso-
ance examinations in the present study. We also recognize
he lack of direct comparison of matched lesion sites with
nd without echo-attenuated plaques in the present study.
owever, matching individual lesions based on its charac-
eristics may be difficult and impractical due to the possi-
ility of a selection bias. Finally, the present study popula-
ion represents relatively stable patients with SAP and UAP,
nd it is not clear if our findings are applicable to patients
fter PCI
ession Multivariable Logistic Regression
95% CI p Value OR 95% CI
1.03–4.89
1.08–5.33
1.00–1.06
0.87–3.36
2.22–32.23 0.003 3.49 1.53–7.93
0.85–3.98
1.01–1.14
1.01–1.15
0.99–1.15
1.14–68.66
1.34–6.56
1.48–8.01 0.017 2.92 1.21–7.06
1.058–5.07
0.98–1.00
intervention; QCA  quantitative coronary angiography; TCFA tion A
c Regr
oronaryith acute myocardial infarction.
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491Conclusions
The present study demonstrates that an echo-attenuated
plaque at the culprit lesion was associated with high-risk
characteristics. Plaque rupture on OCT examination
showed a significant additive predictive value to the pres-
ence of EA on IVUS for post-PCI CK-MB elevation.
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